Study Links GLP-1 Agonists to Reduced Cancer Risk in Nondiabetics | Retatrutide News

GLP-1 agonists are linked to a 41% reduction in cancer risk in nondiabetic adults, according to Medscape. This finding could influence the development o...
Clinical Trials · October 30, 2026